MEMO1 and triple-negative breast carcinoma: To experimentally investigate the link between MEMO1 and the TCA activity suggested by our bioinformatic analyses, we employed a targeted metabolomics approach to measure key TCA metabolites in the MDA-MB-231 triple-negative breast cancer cell line, which exhibits high MEMO1 expression.